JOHN CAMPBELL: Open Payments
NPI 1043252174 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,196 in 153 payments from 14 companies in 2025. Trend: 2023 $2,654 · 2024 $2,278 · 2025 $3,196
Food & beverage: $3,053Education: $143
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $566 |
| Janssen Biotech, Inc. | 30 | $490 |
| Galderma Laboratories, L.P. | 25 | $472 |
| Novartis Pharmaceuticals Corporation | 11 | $319 |
| ABBVIE INC. | 23 | $291 |
| Regeneron Healthcare Solutions, Inc. | 9 | $275 |
| PFIZER INC. | 10 | $177 |
| Lilly USA, LLC | 9 | $150 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $143 |
| UCB, Inc. | 3 | $86 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, SKYRIZI, TALTZ, RINVOQ, CIBINQO, Bimzelx.
Industry payments across TX — which companies pay providers there.
